The role of carbon dioxide in the treatment of symptomatic vascular acrosyndromes[Il ruolo della carbossiterapia nel trattamento sintomatico delle acrosindromi vascolari]

Vascular acrosyndromes constitute a common reason for physician visits. From March 2006 to March 2008 we treated Carbomed CDT evolution device 40 patients (20 with Acrocyanosis and 20 with Raynaud phenomenon), with 1 session for week for a total of 5 weeks with a maintenance every 4 weeks. Treated patients showed benefit from the first session in the 80% of cases (court fine), In 10% of patients said they were partially satisfied with the treatment (court fine), in the remaining 10% sufficiently met (adequate trial). None reported a worsening of symptoms or the occurrence of adverse phenomena. In conclusion we can say that carbossiterapia is useful in the treatment of symptomatic vascular acrosindromi.